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Summary
Closely similar but nonidentical NH2-terminal amino acid sequences have been reported for a
protein or proteins in human neutrophils whose bioactivities is/are diverse (as a serine protease,
antibiotic, and Wegener's granulomatosis autoantigen) but that share(s) several features: localization
in the azurophil granules, a molecular mass of ti29 kD, reactivitywith diisopropylfluorophosphate,
and the ability to degrade elastin. We previously purified one such entity, termed p29b. Using
a monospecific antibody, we have cloned from humanbone marrow a cDNA encoding the complete
p29b protein in its mature form, along with pre- and pro-sequences. The predicted amino acid
sequence agrees closely with the NH2-terminal sequence obtained previously from purified p29b,
as well as with sequences newly obtained from CNBr fragments. The primary structure is highly
homologous to elastase, cathepsin G, T cell granzymes, and other serine proteases, and shares
both the catalytic triad and substrate binding pocket of elastase. Hybridization ofthe full-length
cDNA with restriction enzyme digests of human genomic DNA revealed only one fragment.
This suggests that the closely related species described previously are the same, and can be subsumed
by the term used for the first-described activity, proteinase 3. Proteinase 3 is more abundant
in neutrophils than elastase and has a similar proteolytic profile and specific activity. Thus, proteinase
3 may share the role previously attributed to neutrophil elastase in tissue damage, and has the
potential to function as an antimicrobial agent.
T
he azurophil granules of human neutrophils (PMN) con-
tain two N29-kD proteins, cathepsin G and elastase, that
are active both as neutral serine proteases and as antibiotics
(1-4). These molecules are thought to help PMN form ab-
scesses and damage other inflamed tissues (5), and may par-
ticipate in killing micoorganisms. Recently, we purified an-
other azurophil granule protein of ti29 kD, termed p29b,
whose abundance is intermediate between that of cathepsin
G and elastase, and whose NH2-terminal amino acid se-
quence is highly homologous to theirs (3, 4). Like the latter
proteins, p29b is bifunctional, displaying broad-spectrum an-
timicrobial as well as elastase-like enzymatic activity (3, 4).
The proteolytic profile ofp29b resembled that of a diisopro-
pylfluorophosphate (DFP)t-inhibitable protease of -29 kD
purified by Kao et al. (6) from azurophil granules and shown
to cause emphysema after intratracheal instillation in ham-
'Abbreviations used in this paper: DFP, diisopropylfluorophosphate; IP'TG,
isopropyl-,B-D-thiogalactoside; PR-3, proteinase 3.
sters. Thelatter enzyme was termed proteinase 3 (PR-3), be-
cause it shared thereported properties ofan organic esterhydro-
lase that Baggiolini et al. (7) had so designated afterseparating
it from cathepsin G and elastase on nondenaturing SDS-PAGE.
The NH2-terminal sequence of PR-3 (8) matched that of
p29b in only 9 of 14 residues, leaving theirrelationship unclear.
Interest in p29b and/or PR-3 was heightened by the dis-
covery that autoantibodies characteristic ofWegener's granu-
lomatosis activate PMN (9), stain PMN granules, and can
be used to affinity purify a 29-kD, DFP-binding protease,
termed p29, ACPA, or CANCA (10-13), whose NH2-ter-
minal sequence, as first reported (11, 12), was related but not
identical to those ofp29b (3) or PR-3 (8). Anti-PR-3 mAbs
couldblock the staining of PMN by sera from patients with
Wegener's granulomatosis (13). Meanwhile, a cDNA cloned
from differentiating HIr60 promyelocytic leukemia cells was
predicted to encode a serine protease, termed myeloblastin
(14), whose six NH2-terminal residues matched residues
15-20 in p29b. Addition of a myeloblastin antisense oligode-
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differentiation (14) . Very recently, a preliminary report by
Jenne et al. (15) has revised the NH2-terminal sequence for
the Wegener's autoantigen (12), such that it now matches
all 20 NH2-terminal residues reported for p29b (3), except
for Gln19 in place of Glu19. Based on PCR analysis, Jenne
et al. (15) also proposed a revision of the 5' region of the
myeloblastin cDNA, according to which the deduced NH2-
terminal 20 residues of myeloblastin would likewise match
those of the Wegener's autoantigen and p29b.
We have used a monospecific anti-p29b IgG to clone a
cDNA that encodes the entire mature protein. Below, we
provide the sequence of this clone, compare its deduced amino
acid sequence with the observed sequence of proteolytic frag-
ments of p29b, note the extensive homology of this mole-
cule to cathepsin G, elastase, and the granzymes of T cells,
and demonstrate that only one human genomic DNA frag-
ment appears to hybridize with the p29b cDNA. Thus, it
is likely that the cDNA presented here encodes a single PMN
azurophil granule protein that has the potential for elastino-
lysis, microbial killing, and the regulation ofmyeloid differen-
tiation, and serves as an autoantigen.
Materials and Methods
Amino Acid Sequence ofCNBr Fragments.
￿
50 Pg ofpurified p29b
(3, 4) was incubated with a 500-fold excess (with respect to methi-
onine content) of CNBr in 0.1 N HCl for 48 h at room tempera-
ture in the dark. The samples were subjected to SDS-PAGE.
Resolved peptides were transferred to polyvinylidine difluoride mem-
branes (Millipore Continental Water Systems, Bedford, MA) (16)
and sequenced directly by automated Edman degradation on a gas-
phase sequenator (470; Applied Biosystems, Inc., Foster City, CA).
cDNA Cloning.
￿
A Xgt11 bone human marrow cDNA library
(Clontech, Palo Alto, CA) was plated on Escherichia coli Y1090 (17).
Nitrocellulosefilterlifts saturatedwith isopropyl-A-n-thiogalactoside
(IPTG; Sigma Chemical Co., St. Louis, MO) were dried, blocked
with 5% nonfat dry milk and 0.05% Tween 20 in PBS, rinsed,
probed with a 1:500 dilution of monospecific rabbit anti-p29b IgG
(4) that had been preabsorbedwith E. coliY1090, rinsed, and treated
with goat anti-rabbit IgG conjugated with alkaline phosphatase
(Boehringer Mannheim Biochemicals, Indianapolis, IN). Plaques
positive by a colorimetric phosphatase reaction were purified to
homogeneity, as monitored by rescreening with the antibodies.
Platecultures were lysed in chloroform, clarified by centrifugation,
and rid of bacterial DNA with DNAse (Pharmacia Fine Chem-
icals, Piscataway, NJ). Phagewere collected by ultracentrifugation
(89,500 g, 2 h, 4°C), purified on spin columns ofDEAE cellulose
(5-Prime 3-Prime, Westchester, PA) (18), and the DNA was iso-
lated according to the manufacturer's instructions. The cDNA in-
sert was recovered by restriction with EcoRl (Boehringer Mann-
heim Biochemicals) and electrophoresis in low melt/low gelling
agarose (Bio-Rad Laboratories, Richmond, CA) as visualized with
long-wavelength UV light. The appropriate gel slice was melted
and extracted with phenol and ether, and the DNA was precipi-
tated with ethanol. pBluescript II SK' (Stratagene, La Jolla, CA)
was digested with EcoRl and dephosphorylated (calfintestinal alka-
line phosphatase; Boehringer Mannheim Biochemicals) for inser-
tion of the p29b cDNA with T4 DNA ligase (Stratagene). The
resultant plasmid was used to transform competent E. coli XL1 Blue
(Stratagene) (19). Recombinants were screened by blue/white color
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(0-galactosidase) selection on luria broth agar with ampicillin,
20 mM IPTG, and 80 p.g/ml 5-bromo-4-chloro-3-indolyl-S-D-
galactoside. After transformation of DH5 cells (20), the recom-
binant plasmds were amplified and purified (21). cDNA was se-
quenced by the dideoxynucleotide chain termination method using
double-stranded plasmid DNA as a template (22) with a kit from
U.S. Biochemical Corp. (Cleveland, OH) and deoxyadenosine
5'-[75S]triphosphate (New England Nuclear, Boston, MA). After
initial use ofuniversal primers, sequencing was continued indepen-
dently on both strands with sequentially constructed 20-25-mer
oligonucleotides so as to obtain sequences in regions overlapping
by 20-40bp. Results were analyzedby DNASIS and PROSIS soft-
ware (Hitachi America, Ltd., San Bruno, CA). Alignment to other
proteases was scored according to Lipman and Pearson (23) with
the program FASTR Structural predictions were obtained as de-
scribed (24).
Southern Hybridization.
￿
Humanplacental genomic DNA (10 Rg;
Clontech) was digested to completion with EcoRI, HindIII,
BamHl, Pstl, or BglII (Boehringer Mannheim Biochemicals). The
digests were transferred onto a nylon membrane (Schleicher &
Schuell, Inc., Keene, NH) and hybridized with p29b cDNA [31p]
labeled by random priming (25). Prehybridization (2 h in 5 x Den-
hardt's solution) and hybridization (18 h in 10% dextran sulfate)
were performed at 42'C (high stringency) or 32°C (low stringency)
in 50% (vol/vol) formamidein 6 x SSC/0.5% SDS with 100 hg/ml
sonicated salmon sperm DNA. Filters were washed twice for 15
min at room temperature with 6 x SSC/0.5% SDS, twice at 37°C
and once at 65°C with 1x SSC/0.5% SDS (high stringency), or
twice at room temperature with 2 x SSC/0.1% SDS and twice
at 37°C with 0.25x SSC/0.1% SDS (low stringency).
Results
Cloning.
￿
A humanbone marrow cDNA expression library
in Xgtll was screened with monospecific anti-p29b IgG (4).
One of the positive clones, containing an insert of 1,014 bp,
was purified, subcloned in pBluescript SK', and sequenced
(Fig. 1). The open reading frame of 762 by encodes a
254-amino acid polypeptide, including a 26-residue NH2-
terminal peptide and a 228-residue mature protein. The latter
corresponds to p29b, basedon the following evidence. First,
the deduced amino acid sequence for residues 1-20 (num-
bering for the mature protein) matches exactly the sequence
obtained from the NH2 terminus of the purified protein
(Glu19 was originally observed [3], but Gln19 was detected
in the CNBr peptide sequenced in the present study and con-
forms to the cDNA). Second, two peptides from CNBr
cleavage of purified p29b provided the sequence of55 residues,
and a [3H]DFP-binding tryptic fragment of p29b reported
by Wilde et al. (26) provided another 22 residues; of these
77 residues, 70 were identical to the deduced sequence. Third,
the deduced amino acid composition corresponded closely
to that determined for purified p29b (not shown).
Features ofthe Predicted Structure
￿
The 5' end of the cDNA
encodes a hydrophobic stretch (residues -22 to -9) (Fig.
2) typical of a signal sequence followed by a consensus signal
peptidase cleavage site (Ala-XAla) (27) at - 5 to -3 (Fig.
1). A 24-residue pre-signal peptide (Arg-26 to Ala -3) 50%
homologous to the pre-sequence in the elastase cDNA (28)
is followed by a two-residue pro-peptide (Ala-z-Glu-1); as1 CGGCA000GCCCCCCAGCCCTGCCCTGGCGTCCOTGCTGCTOGCCTTGCTGCTGAGCGGT
-26 R H R P P S P A L A S V L L A L L L 5 G
61 GCTGCCCGAOCTGCOGAGATCOTGGGCGGGCACWGCGCAOCCACACTCCCGGCCCTAC
-6 A A R A A E I V G 6 H E A 0 P H S R P Y
121 AT66CCTCC6TSCAGIITGCG000GMCCC6G6CAGCCACTTCT 60A66CACCTTGATC
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901 G6CTCC660IIGACA6000GBCCCTGCACCTCACCCCACCGT611CCTCJUWCGTTGl1A 960
961 ACTCCAAAAAAMM
￿
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Figure 1.
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Nucleotide and deduced amino acid sequences ofp29b (PR-
3). The nucleotide sequence is numbered from the first base ofthe cDNA
insert after the EcoRl linker site. The deduced amino acid sequence (single-
letter code) is numbered from the NHz-terminal residue of the mature
protein (+1) (3). Regions for which amino acid sequence have been deter-
mined directly are underlined. These include residues 1-20, as determined
earlier from the intact protein (3), 16-44 and 129-154, as determined in
this study from CNBr fragments, and 169-]92, as determined by Wilde
et al. (26) from a Cryptic peptide; the latter contained gaps corresponding
to positions 182 and 189 of p29b. The following discrepancies are dis-
cussed in the text (giving the position, the deduced amino acid, and the
assignment from amino acid sequencing): 29, C for I; 31, G for P; 35,
H for L/V; 37, S for A/V; 44, H for I; 130, W for P; 147, N for R.
Components of the catalytic site triad are boxed. Cysteines are circled.
Potential N-linked glycosylation sites are marked by dots. The stop codon
is marked with a large asterisk. The polyadenylatioa signal is underlined
twice. Amino acid assignments that differ from those deduced for my-
eloblastin (14, 15) are marked by small asterisks; the Arg that forms the
penultimate residue of the reported myeloblastin sequence (14) was not
detected in p29b. Amino acids -8 to +14 are missing from the myelo-
blastin sequence ofBories et al. (14) butare present in the revised sequence
proposed by Jenne et al. (15); amino acids -26 to -9 are not included
in either of the reported sequences. These sequence data have been sub-
mitted to the EMBL, GenBank, and DDBJ Nucleotide Sequence Data-
bases under the accession number X55668 for human mRNA HUMPR-3.
in other leukocyte lysosomal proteases (28-30). However, the
cDNA insert lacks an ATG translation initiationcodon. The
3' end of the cDNA contains a TGA termination codon, as
well as a polyadenylation signal (AATAAA) (31) and a poly(A)
tail, suggesting that the clone encompasses the full-length
sequence for the mature protein.
Mature p29b is predicted to consist of 228 amino aids
with a MI of 25,000 for the polypeptide backbone. Two
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Hydropathy plot of p29b (PR-3) according to the algorithm
of Kyte and Doolittle (42) with a window of n = 6. The lower panel
indicates the distribution of basic (+) and acidic (-) residues.
potential Winked glycosylation sites (Asn-X-SerlThr) are
present, and may account for the apparent isoforms (3, 4).
Eight Cys residues (five clustered in the COOH-terminal third
ofthe molecule) suggest that there may be four intramolecular
disulfide bonds, as in elastase (32) . His", Asp91, and Serf's
correspond to the active site triad typical of serine proteases
(Fig. 1).
After a hydrophobic region (-22 to -9) corresponding
to the presumed signal sequence, the NH2-terminal half of
p29b contains six regions averaging 17 residues each, in which
there is a marked, periodic alternation of hydrophilicity and
hydrophobicity (Fig. 2). The mature protein is predicted by
the Chou-Fasman algorithm (33) to contain three short
stretches of a-helix totalling 8.3%, and 10 fl-sheets totalling
40%. Remarkably, the (3-sheets are all predominantly hydro-
phobic. With 27 basic and 15 acidic amino acids in the ma-
ture protein (Fig. 2, bottom), p29b has an overall calculated
pI of 7.9. Regions of the molecule predicted to be surface
exposed (34) correspond to residues 7-12, 63-72, 83-88,
113-118, 165-168; these 32 residues include four acidic and
eight basic amino acids.
Fig. 3 compares the p29b sequence with that ofother serine
proteases, aligned to maximize homology. p29b exhibits the
highest homology with elastase (54%). There is also consid-
erable homology with the T cell enzymes human lympho-
cyte protease (36%) and granzyme B (33%), and with
cathepsin G (35%), rat mast cell protease II (34%), and
chymotrypsin (30%). Residues 9-16 of p29b comprise the
PHSRPYMA sequence strictly conserved among granzymes
(35). All eight Cys in p29b align with the Cys residues of
elastase; five align with corresponding residues in the other
proteases listed. One of the potential Winked glycosylation
sites in p29b (Asn173) aligns with a corresponding site in
elastase; both enzymes have two such sites. The members
of the catalytic triad (His, Asp, Ser) are located at homolo-
gous positions in all the aligned sequences, flanked by well-
conserved peptides. The residues at -6, 15-17, and 28 rela-
tive to the active site serine are thought to determine the
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specificity of the substrate-binding pocket in serine proteases
(36). In all these positions (Gly 170, Serl91, Phe
192, VaII
93,
Asps; markedby filled diamonds in Fig. 3), p29b matches
elastase, but in four of the five cases there is no match to
the other proteases listed. This suggests that the substrate
specificity of p29b is very similar to that of elastase.
Southern Hybridization.
￿
Human genomic DNA was re-
stricted with five enzymes and hybridized with [32P]-labeled
p29b cDNA. At high stringency, a single strongly hybridizing
band was noted in digests with HindIII (ti20 kb), BamH1
(N12 kb), EcoRl (N9.6 kb), and Bg1II (,'v18 kb). Pstl diges-
tion yielded no hybridizing bands within the resolving range
of the gel. One or two faint additional bands were detected
after digestion with EcoRl and Bg1II. At low stringency,
no changes in band intensity and no additional bands were
observed (not shown). Thus, there appears to be a single
human gene for p29b. This gene may contain introns with
sites for BglII and EcoRl.
Close relatedness amongPR-3, p29b, and the cytoplasmic
autoantigen ofWegener's granulomatosis has emerged from
their subcellular localization, relative abundance, molecular
mass, enzymatic activity, ability to bind DFP, and NH2-
terminal sequences. High homology with the predicted pro-
tein termed myeloblastin was also evident from its cDNA
sequence. However, apparent discrepancies in their partial
amino acid sequences have left unclear the precise interrelat-
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Figure 3.
￿
Alignment ofthe predicted p29b (PR-3) se-
quencewith other serine proteases. Gaps were introduced
to maximize alignment. Conserved residues are boxed.
The His, Asp, Ser residues comprising the catalytic sites
are indicated by asterisks. Residues lining the substrate
binding pocket ofserine proteases (36) are marked by di-
amonds. The human elastase sequence is from reference
28, human cathepsin G (Cat G) fromreference 29, mouse
granzyme B (Gra B) from reference 43, rat mast cell pro-
tease 11 (RMCP 11) from reference 30, human lympho-
cyte protease (HLP) from reference 44, and bovine
chymotrypsin A (Chymo.) from reference 45.
edness of these entities, which were isolated by independent
techniques according to distinct bioactivities. By obtaining
what to our knowledge is the first cDNA sequence encoding
the complete mature form of any one of these species, we
have been able to perform Southern blotting experiments that
strongly suggest the existence of a single hybridizing gene,
even at low stringency. It is highly likely that PR3, p29b,
the predominant cytoplasmic autoantigen of Wegener's
granulomatosis, and myeloblastin are all encoded by this gene.
We propose that the gene product be called proteinase 3
(PR-3), a term with historical precedence (7).
The predicted amino acid sequence of PR-3 differs in 7
of92 residues from the sequences determined from the purified
protein or its fragments. Six of the seven discrepant positions
are highly conserved among serine proteases; in each case,
the conserved amino acid is that predicted by the cDNA.
The discrepancies may arise from ambiguities in amino acid
sequencing. Alternatively, PR-3 may be polymorphic. The
nonconservative nature of the substitutions militates against
this; nonetheless, we plan to test for polymorphism byPCR
techniques. Finally, we cannot exclude the remote possibility
that an additional gene(s) is linked in tandem to PR3 without
intervening sites for the restriction enzymes used in the
Southern blotting experiments. Genomic cloning will resolve
this issue.
The PR-3 cDNA encodes a precursor with signal (pre)
and propeptides typical ofserine proteases. The hydrophobic
prepeptide of24 or more residues (the cDNA may be incom-
plete at the 5' end) may target PR-3 to the endoplasmic retic-Figure 4 .
￿
Southern blot of human genomic DNA with p29b (PR-3)
cDNA as a probe. Human placental genomicDNA was digested to com-
pletion with five restriction enzymes and subjected to electrophoresis in
0.7% agarose. (A) The gel was stained with ethidium bromide and pho-
tographed under short-wavelength UV light to show the extent of diges-
tion of the genomic DNA and the migration of size markers (left lane)
derived from phage XDNA digested with HindlIl (23, 9 .6, 6.6, 4.4, 2 .3,
2.0 kb) . (B) The digests were transferred to a nylon membrane, hybridized
with [32PJ-labeled p29b (PR-3) cDNA under high stringency, and washed
as described in Materials and Methods, then autoradiographed with an
intensifying screen for 4 d at -70°C.
ulum and be removed in the process . The two-residue pro-
peptide, which resembles that of elastase, cathepsin G, and
rat mast cell protease II, may confer zymogen status. The
mature protein shares not only the His, Asp, Ser catalytic
triad with other serine proteases, but also the sequence at
residues 9-16, which constitutes a hallmark of granzymes .
Finally, PR-3 shares the substrate binding pocket of elastase
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(32) . Given the ability ofPR-3 to hydrolyze the same sub-
strates as elastase (4, 6) with a similar specific activity (4),
and considering that twice as much PR-3 as elastase can be
purified from PMN (4), PR-3 may share a major role in inflam-
matory states wherePMN elastase has been implicated (5, 28) .
The difference between the calculated pI ofPR-3 (7.9) and
the experimental value (9.1, reference 6; >9.5, reference 4)
might reflect the predicted preferential distribution of posi-
tively charged amino acids on the surface of the protein . Such
is the case with elastase, in which Arg residues are exclu-
sively surface disposed (32) . It will be of interest to deter-
mine the three-dimensional structure of PR-3, both to confirm
the predicted distribution of surface charges and to learn
whether the alternation ofhydrophilic and hydrophobic regions
in the primary sequence (Fig . 2) is associated with amphiphi-
licity, a functionally important property proposed for a va-
riety of antimicrobial polypeptides (reviewed in reference 37) .
By X-ray crystallography, elastase shares the two short ci-helices
and predominant, hydrophobic 0-sheets predicted for PR-3
(32) . However, the hydrophilic-hydrophobic periodicity seen
inPR-3 is not observed in elastase or cathepsin G (not shown) .
Although PR-3 is 35% homologous to cathepsin G, PR-3
lacks the peptides IIGGR andHPQYNQR, which were pro-
posed to contribute to cathepsin G's antibacterial activity (38).
Nor does PR-3 display homology to any of the nonproteo-
lytic antibacterial proteins fromhuman or bovine neutrophils
whose primary sequences have been reported (37, 39-41) . Of
10 antimicrobial proteins ofknown sequence in the azurophil
granules of human PMN, two are thought to be unique in
primary structure Oysozyme [39] and bactericidal/permeability
increasing factor [41]), while the remaining eight fall into
two families of four members each: the defensins (3, 40) on
the one hand, and cathepsin G, elastase, PR-3, and azurocidin
(3, 4) on the other hand. Azurocidin has a Gly for Ser substi-
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